GoodRx Holdings, Inc. (NASDAQ:GDRX) Q4 2023 Earnings Conference Call February 29, 2024 8:00 AM ET

Company Participants

Whitney Notaro - VP, IR

Scott Wagner - Interim CEO

Karsten Voermann - CFO

Conference Call Participants

Stephanie Davis - Barclays

Lisa Gill - JPMorgan

Charles Rhyee - TD Cowen

Michael Cherny - Leerink

Jailendra Singh - Truist

Jian Li - Evercore ISI

Allen Lutz - Bank of America

Daniel Grosslight - Citi

Craig Hettenbach - Morgan Stanley

Scott Schoenhaus - KeyBanc

Stan Berenshteyn - Wells Fargo

Dylan Finley - UBS

George Hill - Deutsche Bank

Eric Sheridan - Goldman Sachs

Operator

Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2023 Earnings Call. As a reminder, today's conference call is being recorded.

I would now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Ms. Notaro, you may begin.

Whitney Notaro

Thank you, operator. Good morning, everyone, and welcome to GoodRx's earnings conference call for the fourth quarter and full year 2023. Joining me today are Scott Wagner, our Interim Chief Executive Officer; and Karsten Voermann, our Chief Financial Officer.

Before we begin, I'd like to remind everyone that this call will contain forward-looking statements. All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements including, without limitation, statements regarding management's plans, strategies, goals and objectives, our market opportunity, our anticipated financial performance, underlying trends in the business, our value proposition, our potential for growth, collaborations and partnerships with third parties, including our integrated savings program, our hybrid retail direct and PBM contracting approach, anticipated impacts of the deprioritization of certain solutions under our pharma manufacturer solutions offering and our cost savings initiatives, expected impact of the wind down of Kroger Savings Club, the amount, timing and benefits of our new share repurchase program, the expected impact of the macroeconomic environment on our business, and the expected impact of recent outages disclosed by UnitedHealth Group.

These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors. These factors may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Factors discussed in the Risk Factors section of our annual report on Form 10-K for the year ended December 31, 2023, and our other filings with the Securities and Exchange Commission could cause actual results to differ materially from those indicated by the forward-looking statements made on this call.